EPISODE · Aug 13, 2025 · 44 MIN
Droht SaaS Aktien der Nokia Moment? / Novo Nordisks orales Medikament besser als das von Eli Lilly?
from Goldesel x Investflow - Aktientalk · host Michael Flender & Daniel Wassmer
Embed this episode
NOW PLAYING
Droht SaaS Aktien der Nokia Moment? / Novo Nordisks orales Medikament besser als das von Eli Lilly?
0:00
44:54
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Goldesel x Investflow - Aktientalk?
This episode is 44 minutes long.
When was this Goldesel x Investflow - Aktientalk episode published?
This episode was published on August 13, 2025.
Can I download this Goldesel x Investflow - Aktientalk episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!